HowShorted

How shorted is VYNE Therapeutics Inc.?

0.36%
of shares outstanding reported short · settlement date 29 May 2026
vs previous report
−0.01
5 reports (~10 weeks)
−1.53
Aggregate net short position time series for VYNE Therapeutics Inc.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
29 May 20260.36%−0.01
15 May 20260.37%−1.28
13 Feb 20261.65%−0.49
30 Jan 20262.14%−0.81
15 Jan 20262.95%+1.06
15 Dec 20251.89%−0.43
28 Nov 20252.32%−2.42
14 Nov 20254.74%+1.38
31 Oct 20253.36%+0.23
15 Oct 20253.13%−1.29
30 Sep 20254.42%+0.37
15 Sep 20254.05%−1.20
29 Aug 20255.25%−3.06
15 Aug 20258.31%−4.23
31 Jul 202512.54%–

Frequently asked questions

How shorted is VYNE Therapeutics Inc. right now?
0.36% of VYNE Therapeutics Inc.'s (VYNE) shares outstanding were reported short for settlement date 29 May 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.